Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer
Higher metabolic tumor volume is significantly associated with worse overall survival and combined with TNM staging, it provides more precise information about the disease prognosis in locally advanced NSCLC treated with chemoradiotherapy compared to TNM alone. As a PET parameter with volumetric information, MTV represents a useful addition to TNM.
Authors
- Jörg Sahlmann (ORCID: https://orcid.org/0000-0003-3023-3318)
- Matthias Miederer (ORCID: https://orcid.org/0000-0001-5075-5995)
- Eleni Gkika (ORCID: https://orcid.org/0000-0001-5455-252X)
- Mathias Schreckenberger
- Alexander Brose (ORCID: https://orcid.org/0000-0001-8033-6855)
- J. König (ORCID: https://orcid.org/0000-0003-4683-0360)
- Isabelle Miederer (ORCID: https://orcid.org/0000-0002-1148-7964)
- Tanja Schimek‐Jasch (ORCID: https://orcid.org/0000-0003-2027-9320)
- Ursula Nestle
- Jutta Kappes (ORCID: https://orcid.org/0009-0000-9569-7696)
Institutions
- German Cancer Research Center (DE)
- Johannes Gutenberg University Mainz (DE)
- Justus-Liebig-Universität Gießen (DE)
- Heidelberg University (DE)
- University Hospital Bonn (DE)
- University Medical Center Freiburg (DE)
- Helmholtz-Zentrum Dresden-Rossendorf (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Kliniken Maria Hilf (DE)
- National Center for Tumor Diseases (DE)
- Katholisches Klinikum Koblenz (DE)
- German Center for Lung Research (DE)
- Universities of Giessen and Marburg Lung Center (DE)
- Diabetesinstitut Heidelberg (DE)
- University Hospital Carl Gustav Carus (DE)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1186/s40644-024-00811-7
- Citations
- 3
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 1.21
Funders
- Deutsche Krebshilfe